Hecht Jacqueline T, Coustry Francoise, Veerisetty Alka C, Hossain Mohammad G, Posey Karen L
Department of Pediatrics, McGovern Medical School The University of Texas Health Science Center at Houston (UTHealth) Houston TX USA.
UTHealth School of Dentistry Houston TX USA.
JBMR Plus. 2021 Jan 22;5(3):e10456. doi: 10.1002/jbm4.10456. eCollection 2021 Mar.
Misfolding mutations in cartilage oligomeric matrix protein (COMP) cause it to be retained within the endoplasmic reticulum (ER) of chondrocytes, stimulating a multitude of damaging cellular responses including ER stress, inflammation, and oxidative stress, which ultimately culminates in the death of growth plate chondrocytes and pseudoachondroplasia (PSACH). Previously, we demonstrated that an antioxidant, resveratrol, substantially reduces the intracellular accumulation of mutant-COMP, dampens cellular stress, and lowers the level of growth plate chondrocyte death. In addition, we showed that resveratrol reduces mammalian target of rapamycin complex 1 (mTORC1) signaling, suggesting a potential mechanism. In this work, we investigate the role of autophagy in treatment of COMPopathies. In cultured chondrocytes expressing wild-type COMP or mutant-COMP, resveratrol significantly increased the number of Microtubule-associated protein 1A/1B-light chain 3 (LC3) vesicles, directly demonstrating that resveratrol-stimulated autophagy is an important component of the resveratrol-driven mechanism responsible for the degradation of mutant-COMP. Moreover, pharmacological inhibitors of autophagy suppressed degradation of mutant-COMP in our established mouse model of PSACH. In contrast, blockage of the proteasome did not substantially alter resveratrol clearance of mutant-COMP from growth plate chondrocytes. Mechanistically, resveratrol increased SIRT1 and PP2A expression and reduced MID1 expression and activation of phosphorylated protein kinase B (pAKT) and mTORC1 signaling in growth plate chondrocytes, allowing clearance of mutant-COMP by autophagy. Importantly, we show that optimal reduction in growth plate pathology, including decreased mutant-COMP retention, decreased mTORC1 signaling, and restoration of chondrocyte proliferation was attained when treatment was initiated between birth to 1 week of age in MT-COMP mice, translating to birth to approximately 2 years of age in children with PSACH. These results clearly demonstrate that resveratrol stimulates clearance of mutant-COMP by an autophagy-centric mechanism. © 2020 The Authors. published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.
软骨寡聚基质蛋白(COMP)的错误折叠突变导致其滞留在软骨细胞的内质网(ER)内,引发多种有害的细胞反应,包括内质网应激、炎症和氧化应激,最终导致生长板软骨细胞死亡和假性软骨发育不全(PSACH)。此前,我们证明抗氧化剂白藜芦醇可显著减少突变型COMP的细胞内积累,减轻细胞应激,并降低生长板软骨细胞的死亡水平。此外,我们还表明白藜芦醇可降低哺乳动物雷帕霉素靶蛋白复合物1(mTORC1)信号传导,提示了一种潜在机制。在这项研究中,我们探讨自噬在COMP相关疾病治疗中的作用。在表达野生型COMP或突变型COMP的培养软骨细胞中,白藜芦醇显著增加了微管相关蛋白1A/1B轻链3(LC3)囊泡的数量,直接证明白藜芦醇刺激的自噬是白藜芦醇驱动的负责降解突变型COMP机制的重要组成部分。此外,自噬的药理抑制剂在我们建立的PSACH小鼠模型中抑制了突变型COMP的降解。相比之下,蛋白酶体的阻断并没有显著改变白藜芦醇从生长板软骨细胞中清除突变型COMP的能力。从机制上讲,白藜芦醇增加了SIRT1和PP2A的表达,降低了MID1的表达以及磷酸化蛋白激酶B(pAKT)和mTORC1信号的激活,从而通过自噬清除突变型COMP。重要的是,我们发现,在MT-COMP小鼠出生至1周龄之间开始治疗时,生长板病理的改善最为明显,包括突变型COMP滞留减少、mTORC1信号传导降低以及软骨细胞增殖恢复,这相当于PSACH儿童从出生至大约2岁。这些结果清楚地表明,白藜芦醇通过以自噬为中心的机制刺激突变型COMP的清除。© 2020作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。